Comparing rigid and deformable dose registration for high dose thoracic re-irradiation.

For patients with locally-recurrent lung cancer, high dose thoracic re-irradiation can prolong survival. Deformable image registration improves the accuracy with which initial treatments are accounted for compared to rigid image registration. Using deformable image registration will improve correlative toxicity data, and may reduce toxicity for selected patients undergoing re-irradiation.

[1]  Stewart Gaede,et al.  An evaluation of an automated 4D-CT contour propagation tool to define an internal gross tumour volume for lung cancer radiotherapy. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  Benjamin Movsas,et al.  Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. , 2011, International journal of radiation oncology, biology, physics.

[3]  M. Partridge,et al.  Adaptive radiotherapy for locally advanced non-small-cell lung cancer does not underdose the microscopic disease and has the potential to increase tumor control. , 2011, International journal of radiation oncology, biology, physics.

[4]  Wilfred Levin,et al.  Reirradiation after radical radiation therapy: a survey of patterns of practice among Canadian radiation oncologists. , 2008, International journal of radiation oncology, biology, physics.

[5]  S. Senan,et al.  Clinical application of a novel hybrid intensity-modulated radiotherapy technique for stage III lung cancer and dosimetric comparison with four other techniques. , 2012, International journal of radiation oncology, biology, physics.

[6]  David R. Haynor,et al.  Nonrigid multimodality image registration , 2001, SPIE Medical Imaging.

[7]  D. Wood,et al.  Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes. , 2008, The Annals of thoracic surgery.

[8]  T. Nakajima,et al.  Reirradiation for locally recurrent lung cancer previously treated with radiation therapy. , 2002, International journal of radiation oncology, biology, physics.

[9]  A Harvey,et al.  Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  Suresh Senan,et al.  Time and dose-related changes in radiological lung density after concurrent chemoradiotherapy for lung cancer. , 2011, Lung cancer.

[11]  Vladimir Pekar,et al.  Assessment of a model-based deformable image registration approach for radiation therapy planning. , 2007, International journal of radiation oncology, biology, physics.

[12]  B. Jeremic,et al.  Clinical prognostic factors in patients with locally advanced (stage III) nonsmall cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapy , 2011, Cancer.

[13]  Benjamin Movsas,et al.  Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. , 2011, Journal of the National Cancer Institute.

[14]  B. Jeremic,et al.  Chest reirradiation with external beam radiotherapy for locally recurrent non-small-cell lung cancer: a review. , 2011, International journal of radiation oncology, biology, physics.

[15]  V. Rusch,et al.  Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial , 2009, The Lancet.